Xilio Therapeutics, Inc. (XLO)

NASDAQ: XLO · Real-Time Price · USD

1.280

+0.342 (36.46%)

At close: Dec 20, 2024, 4:00 PM

1.240

-0.040 (-3.13%)

After-hours: Dec 20, 2024, 7:59 PM EST

Xilio Therapeutics Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Xilio Therapeutics stock has a target of 4.00, which predicts an increase of 212.50% from the current stock price of 1.28.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$4.00	$4.00	$4.00	$4.00
Change	+212.50%	+212.50%	+212.50%	+212.50%

* Price targets were last updated on Nov 8, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for XLO is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '24	Aug '24	Sep '24	Oct '24	Nov '24	Dec '24
Strong Buy	1	1	1	1	0	0
Buy	2	2	2	2	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Dane Leone Raymond James	Raymond James	Buy Maintains $6 → $4	Buy	Maintains	$6 → $4	+212.50%	Nov 8, 2024
Matthew Barcus Chardan Capital	Chardan Capital	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+446.88%	May 30, 2023
Matthew Barcus Chardan Capital	Chardan Capital	Strong Buy Reiterates $7	Strong Buy	Reiterates	$7	+446.88%	May 11, 2023
Michael Ulz Morgan Stanley	Morgan Stanley	Buy Maintains $20 → $10	Buy	Maintains	$20 → $10	+681.25%	Jan 27, 2023
Matthew Barcus Chardan Capital	Chardan Capital	Strong Buy Initiates $7	Strong Buy	Initiates	$7	+446.88%	Dec 21, 2022

More Analyst Ratings

Financial Forecast

Revenue This Year

7.77M

Revenue Next Year

36.43M

from 7.77M

368.76%

from 7.77M

EPS This Year

-1.15

from -2.78

EPS Next Year

-0.51

from -1.15

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	-	7.77M	36.43M	32.83M
Revenue Growth	-	-	-	-	-	-	368.76%	-9.89%
EPS	-42.29	-105.42	-13.52	-3.22	-2.78	-1.15	-0.51	-0.46
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	11.8M	78.8M	78.8M
Avg	7.8M	36.4M	32.8M
Low	4.9M	9.8M	n/a

Revenue Growth

Revenue Growth	2024	2025	2026
High	-	913.4%	116.2%
Avg	-	368.8%	-9.9%
Low	-	26.1%	-

EPS Forecast

EPS	2024	2025	2026
High	-1.10	-	-0.45
Avg	-1.15	-0.51	-0.46
Low	-1.19	-0.83	-0.46

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.